Advertisement
Screener

CHINA PHARMA HOLDINGS, INC. (CPHI) Selling Expense

2.8 / 5 stars · 68/120 Roast Me

CHINA PHARMA HOLDINGS, INC. Selling Expense

CHINA PHARMA HOLDINGS, INC. (CPHI) reported Selling Expense of $113.76 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:SellingExpense · last filed 2026-08-14

  • CHINA PHARMA HOLDINGS, INC. selling expense for the quarter ending 2026-06-30 was $113.76K, a 12.31% increase year-over-year.
  • CHINA PHARMA HOLDINGS, INC. selling expense for the quarter ending 2026-03-31 was $95.60K, a 9.74% increase year-over-year.
  • CHINA PHARMA HOLDINGS, INC. selling expense for the quarter ending 2025-12-31 was $109.34K, a 37.37% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. selling expense for the quarter ending 2025-09-30 was $78.04K, a 42.02% decline year-over-year.
  • CHINA PHARMA HOLDINGS, INC. selling expense for fiscal 2025 was $375.79K, a 28.94% decline from fiscal 2024.
  • CHINA PHARMA HOLDINGS, INC. selling expense for fiscal 2024 was $528.82K, a 32.23% decline from fiscal 2023.
  • CHINA PHARMA HOLDINGS, INC. selling expense for fiscal 2023 was $780.33K, a 27.06% decline from fiscal 2022.
  • CHINA PHARMA HOLDINGS, INC. selling expense for fiscal 2022 was $1.07M, a 28.44% decline from fiscal 2021.
Period endSelling Expense 3 monthSelling Expense 6 monthSelling Expense 9 monthSelling Expense 12 month
2026-06-30$113.76K
10-Q · filed 2026-08-14
$209.36K
10-Q · filed 2026-08-14
$318.70K
derived: sum of 3 quarters · filed 2026-08-14
$396.75K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$95.60K
10-Q · filed 2026-05-15
$204.94K
derived: sum of 2 quarters · filed 2026-05-15
$282.98K
derived: sum of 3 quarters · filed 2026-05-15
$384.27K
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$109.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01
$187.38K
derived: sum of 2 quarters · filed 2026-04-01
$288.68K
derived: sum of 3 quarters · filed 2026-08-14
$375.79K
10-K · filed 2026-04-01
2025-09-30$78.04K
10-Q · filed 2025-11-12
$179.33K
derived: sum of 2 quarters · filed 2026-08-14
$266.44K
10-Q · filed 2025-11-12
$441.02K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$101.29K
10-Q · filed 2026-08-14
$188.40K
10-Q · filed 2026-08-14
$362.98K
derived: sum of 3 quarters · filed 2026-08-14
$497.58K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$87.11K
10-Q · filed 2026-05-15
$261.69K
derived: sum of 2 quarters · filed 2026-05-15
$396.29K
derived: sum of 3 quarters · filed 2026-05-15
$507.75K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$174.58K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01
$309.18K
derived: sum of 2 quarters · filed 2026-04-01
$420.64K
derived: sum of 3 quarters · filed 2026-04-01
$528.82K
10-K · filed 2026-04-01
2024-09-30$134.60K
10-Q · filed 2025-11-12
$246.06K
derived: sum of 2 quarters · filed 2025-11-12
$354.25K
10-Q · filed 2025-11-12
$613.80K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$111.45K
10-Q · filed 2025-08-14
$219.64K
10-Q · filed 2025-08-14
$479.19K
derived: sum of 3 quarters · filed 2025-08-14
$685.72K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$108.19K
10-Q · filed 2025-05-14
$367.74K
derived: sum of 2 quarters · filed 2025-05-14
$574.26K
derived: sum of 3 quarters · filed 2025-05-14
$744.08K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$259.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$466.08K
derived: sum of 2 quarters · filed 2025-03-31
$635.90K
derived: sum of 3 quarters · filed 2025-03-31
$780.33K
10-K · filed 2025-03-31
2023-09-30$206.52K
10-Q · filed 2024-11-13
$376.34K
derived: sum of 2 quarters · filed 2024-11-13
$520.78K
10-Q · filed 2024-11-13
$885.17K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$169.82K
10-Q · filed 2024-08-14
$314.25K
10-Q · filed 2024-08-14
$678.65K
derived: sum of 3 quarters · filed 2024-08-14
$938.02K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$144.43K
10-Q · filed 2023-05-12
$508.83K
derived: sum of 2 quarters · filed 2024-04-01
$768.21K
derived: sum of 3 quarters · filed 2024-04-01
$1.03M
derived: sum of 4 quarters · filed 2024-04-01
2022-12-31$364.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$623.77K
derived: sum of 2 quarters · filed 2024-04-01
$890.22K
derived: sum of 3 quarters · filed 2024-04-01
$1.07M
10-K · filed 2024-04-01
2022-09-30$259.38K
10-Q · filed 2023-11-13
$525.83K
derived: sum of 2 quarters · filed 2023-11-13
$705.39K
10-Q · filed 2023-11-13
$1.24M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$266.45K
10-Q · filed 2023-08-14
$446.01K
10-Q · filed 2023-08-14
$982.91K
derived: sum of 3 quarters · filed 2023-08-14
$1.12M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$179.56K
10-Q · filed 2023-05-12
$716.46K
derived: sum of 2 quarters · filed 2023-05-12
$850.75K
derived: sum of 3 quarters · filed 2023-05-12
$1.30M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$536.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$671.19K
derived: sum of 2 quarters · filed 2023-03-30
$1.12M
derived: sum of 3 quarters · filed 2023-03-30
$1.50M
10-K · filed 2023-03-30
2021-09-30$134.29K
10-Q · filed 2022-11-14
$579.77K
derived: sum of 2 quarters · filed 2022-11-14
$958.11K
10-Q · filed 2022-11-14
$1.47M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$445.48K
10-Q · filed 2022-08-11
$823.81K
10-Q · filed 2022-08-11
$1.33M
derived: sum of 3 quarters · filed 2022-08-11
$1.99M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$378.33K
10-Q · filed 2022-05-12
$885.90K
derived: sum of 2 quarters · filed 2022-05-12
$1.54M
derived: sum of 3 quarters · filed 2022-05-12
$2.27M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$507.57K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$1.16M
derived: sum of 2 quarters · filed 2022-03-30
$1.89M
derived: sum of 3 quarters · filed 2022-03-30
$2.22M
10-K · filed 2022-03-30
2020-09-30$654.09K
10-Q · filed 2021-11-12
$1.38M
derived: sum of 2 quarters · filed 2021-11-12
$1.71M
10-Q · filed 2021-11-12
$2.46M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$727.64K
10-Q · filed 2021-08-13
$1.05M
10-Q · filed 2021-08-13
$1.81M
derived: sum of 3 quarters · filed 2021-08-13
$2.42M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$326.10K
10-Q · filed 2021-05-14
$1.08M
derived: sum of 2 quarters · filed 2021-05-14
$1.69M
derived: sum of 3 quarters · filed 2021-05-14
$2.20M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$754.94K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
$1.37M
derived: sum of 2 quarters · filed 2021-03-26
$1.87M
derived: sum of 3 quarters · filed 2021-03-26
$2.35M
10-K · filed 2021-03-26
2019-09-30$613.11K
10-Q · filed 2020-11-13
$1.12M
derived: sum of 2 quarters · filed 2020-11-13
$1.60M
10-Q · filed 2020-11-13
$2.49M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$505.87K
10-Q · filed 2020-08-13
$984.56K
10-Q · filed 2020-08-13
$1.88M
derived: sum of 3 quarters · filed 2020-08-13
$2.81M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$478.69K
10-Q · filed 2020-05-14
$1.37M
derived: sum of 2 quarters · filed 2020-05-14
$2.30M
derived: sum of 3 quarters · filed 2020-05-14
$3.02M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$896.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$1.82M
derived: sum of 2 quarters · filed 2020-03-30
$2.54M
derived: sum of 3 quarters · filed 2020-03-30
$3.22M
10-K · filed 2020-03-30
2018-09-30$925.65K
10-Q · filed 2019-11-14
$1.64M
derived: sum of 2 quarters · filed 2019-11-14
$2.32M
10-Q · filed 2019-11-14
$3.57M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$716.22K
10-Q · filed 2019-08-14
$1.39M
10-Q · filed 2019-08-14
$2.65M
derived: sum of 3 quarters · filed 2019-08-14
$3.33M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$678.33K
10-Q · filed 2019-05-14
$1.93M
derived: sum of 2 quarters · filed 2019-05-14
$2.62M
derived: sum of 3 quarters · filed 2019-05-14
$3.42M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28
$1.94M
derived: sum of 2 quarters · filed 2019-03-28
$2.74M
derived: sum of 3 quarters · filed 2019-03-28
$3.46M
10-K · filed 2019-03-28
2017-09-30$686.83K
10-Q · filed 2018-11-14
$1.49M
derived: sum of 2 quarters · filed 2018-11-14
$2.21M
10-Q · filed 2018-11-14
$3.49M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$803.43K
10-Q · filed 2018-08-14
$1.52M
10-Q · filed 2018-08-14
$2.80M
derived: sum of 3 quarters · filed 2018-08-14
$3.73M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$717.64K
10-Q · filed 2018-05-14
$2.00M
derived: sum of 2 quarters · filed 2018-05-14
$2.93M
derived: sum of 3 quarters · filed 2018-05-14
$3.79M
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02
$2.21M
derived: sum of 2 quarters · filed 2018-04-02
$3.07M
derived: sum of 3 quarters · filed 2018-04-02
$4.04M
10-K · filed 2018-04-02
2016-09-30$927.19K
10-Q · filed 2017-11-14
$1.78M
derived: sum of 2 quarters · filed 2017-11-14
$2.75M
10-Q · filed 2017-11-14
$3.89M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$857.69K
10-Q · filed 2017-08-14
$1.83M
10-Q · filed 2017-08-14
$2.96M
derived: sum of 3 quarters · filed 2017-08-14
$4.12M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$968.51K
10-Q · filed 2017-05-11
$2.11M
derived: sum of 2 quarters · filed 2017-05-11
$3.26M
derived: sum of 3 quarters · filed 2017-05-11
$4.27M
derived: sum of 4 quarters · filed 2017-05-11
2015-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
$2.29M
derived: sum of 2 quarters · filed 2017-03-31
$3.31M
derived: sum of 3 quarters · filed 2017-03-31
$4.29M
10-K · filed 2017-03-31
2015-09-30$1.16M
10-Q · filed 2016-11-14
$2.17M
derived: sum of 2 quarters · filed 2016-11-14
$3.16M
10-Q · filed 2016-11-14
$4.31M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$1.01M
10-Q · filed 2016-08-11
$2.00M
10-Q · filed 2016-08-11
$3.15M
derived: sum of 3 quarters · filed 2016-08-11
$3.90M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31$988.95K
10-Q · filed 2016-05-16
$2.14M
derived: sum of 2 quarters · filed 2016-05-16
$2.89M
derived: sum of 3 quarters · filed 2016-05-16
$3.52M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$1.90M
derived: sum of 2 quarters · filed 2016-03-30
$2.53M
derived: sum of 3 quarters · filed 2016-03-30
$3.35M
10-K · filed 2016-03-30
2014-09-30$745.98K
10-Q · filed 2015-12-28
$1.37M
derived: sum of 2 quarters · filed 2015-12-28
$2.19M
10-Q · filed 2015-12-28
$3.04M
derived: sum of 4 quarters · filed 2015-12-28
2014-06-30$627.44K
10-Q · filed 2015-12-28
$1.45M
10-Q · filed 2015-12-28
$2.30M
derived: sum of 3 quarters · filed 2015-12-28
$3.22M
derived: sum of 4 quarters · filed 2015-12-28
2014-03-31$820.40K
10-Q · filed 2015-12-28
$1.67M
derived: sum of 2 quarters · filed 2015-12-28
$2.59M
derived: sum of 3 quarters · filed 2015-12-28
$3.29M
derived: sum of 4 quarters · filed 2015-12-28
2013-12-31$849.31K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-28
$1.77M
derived: sum of 2 quarters · filed 2015-12-28
$2.47M
derived: sum of 3 quarters · filed 2015-12-28
$3.28M
10-K · filed 2015-12-28
2013-09-30$921.85K
10-Q · filed 2014-11-14
$1.62M
derived: sum of 2 quarters · filed 2014-11-14
$2.44M
10-Q · filed 2014-11-14
$3.34M
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$701.69K
10-Q · filed 2014-08-14
$1.51M
10-Q · filed 2014-08-14
$2.42M
derived: sum of 3 quarters · filed 2014-08-14
$3.27M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$812.05K
10-Q · filed 2014-05-15
$1.72M
derived: sum of 2 quarters · filed 2014-05-15
$2.57M
derived: sum of 3 quarters · filed 2014-05-15
$3.45M
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31$903.04K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20
$1.76M
derived: sum of 2 quarters · filed 2014-03-20
$2.64M
derived: sum of 3 quarters · filed 2014-03-20
$3.54M
10-K · filed 2014-03-20
2012-09-30$856.17K
10-Q · filed 2013-11-14
$1.74M
derived: sum of 2 quarters · filed 2013-11-14
$2.63M
10-Q · filed 2013-11-14
$3.66M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$881.95K
10-Q · filed 2013-08-14
$1.78M
10-Q · filed 2013-08-14
$2.81M
derived: sum of 3 quarters · filed 2013-08-14
$3.81M
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$894.06K
10-Q · filed 2013-05-14
$1.92M
derived: sum of 2 quarters · filed 2013-05-14
$2.93M
derived: sum of 3 quarters · filed 2013-05-14
$3.73M
derived: sum of 4 quarters · filed 2013-05-14
2011-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
$2.04M
derived: sum of 2 quarters · filed 2013-03-14
$2.84M
derived: sum of 3 quarters · filed 2013-03-14
$3.44M
10-K · filed 2013-03-14
2011-09-30$1.01M
10-Q · filed 2012-11-14
$1.81M
derived: sum of 2 quarters · filed 2012-11-14
$2.41M
10-Q · filed 2012-11-14
$3.30M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$799.22K
10-Q · filed 2012-08-14
$1.40M
10-Q · filed 2012-08-14
$2.29M
derived: sum of 3 quarters · filed 2012-08-14
$2.74M
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$604.48K
10-Q · filed 2012-05-14
$1.49M
derived: sum of 2 quarters · filed 2012-05-14
$1.94M
derived: sum of 3 quarters · filed 2012-05-14
$2.56M
derived: sum of 4 quarters · filed 2012-05-14
2010-12-31$889.06K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14
$1.34M
derived: sum of 2 quarters · filed 2012-03-14
$1.96M
derived: sum of 3 quarters · filed 2012-03-14
$2.54M
10-K · filed 2012-03-14
2010-09-30$449.30K
10-Q/A · filed 2012-03-06
$1.07M
derived: sum of 2 quarters · filed 2012-03-06
$1.65M
10-Q/A · filed 2012-03-06
2010-06-30$621.58K
10-Q/A · filed 2011-09-06
$1.20M
10-Q/A · filed 2011-09-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30